TD Waterhouse Canada’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
TD Waterhouse Canada's IBB Position: Q2 2026 in Review
TD Waterhouse Canada reduced its iShares Biotechnology ETF (IBB) stake by 2.3% in Q2 2026, selling an estimated $6.88K and leaving 1,668 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #971.
TD Waterhouse Canada first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $4M in Q4 2025. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- TD Waterhouse Canada held 1,668 shares of iShares Biotechnology ETF worth $317K as of Q2 2026.
- TD Waterhouse Canada sold 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
- iShares Biotechnology ETF made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #971 holding.
- TD Waterhouse Canada first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
- TD Waterhouse Canada's iShares Biotechnology ETF position peaked at $4M in Q4 2025.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.